Rheumatoid Arthritis - Related Resources
Other evidence summaries
- Combination therapy appears to be better and not more hazardous than single treatment in induction of remission in early rheumatoid arthritis. The combination strategy as an initial therapy seems to increase the efficacy of the treatment in at least a proportion of patients with early rheumatoid arthritis .
- The delay of a few months from the onset of symptoms to institution of therapy appears to decrease the ability of the traditional single-drug strategy to induce remission in early RA .
- Aggressive combination-DMARD therapy with sulfasalazine, methotrexate, hydroxychloroquine, and prednisolone appears to prevent or retard the development of rheumatoid atlantoaxial disorders .
- Fish oil appears to have a modest effect on tender joint count and morning stiffness in rheumatoid arthritis, and reduces failure of triple disease-modifying antirheumatic drug (DMARD) therapy in patients with recent-onset rheumatoid arthritisFish Oil in Rheumatoid Arthritis.
- Paraffin wax baths may have some effect in improving symptoms in rheumatoid arthritic hands with few side effects .
- Fasting followed by vegetarian diet may improve symptoms in patients with rheumatoid arthritis .
Clinical guidelines
- Rausch Osthoff AK, Niedermann K, Braun J et al. 2018 EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis. Ann Rheum Dis 2018 Jul 11; [Epub ahead of print]. [PubMed]
- Geenen R, Overman CL, Christensen R et al. EULAR recommendations for the health professional's approach to pain management in inflammatory arthritis and osteoarthritis. Ann Rheum Dis 2018;77(6):797-807. [PubMed]
- Smolen JS, Landewé R, Bijlsma J et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis 2017;76(6):960-977. [PubMed]
- Agca R, Heslinga SC, Rollefstad S et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis 2017;76(1):17-28. [PubMed]
- Götestam Skorpen C, Hoeltzenbein M, Tincani A et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis 2016;75(5):795-810. [PubMed]
- Buckley L, Guyatt G, Fink HA et al. 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. Arthritis Care Res (Hoboken) 2017;69(8):1095-1110. [PubMed]
- Singh JA, Saag KG, Bridges SL Jr et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Rheumatol 2016;68(1):1-26. [PubMed]
- Smolen JS, Breedveld FC, Burmester GR et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis 2016;75(1):3-15. [PubMed]
- Singh JA, Furst DE, Bharat A et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012;64(5):625-39. [PubMed]
- Management of early rheumatoid arthritis. Scottish Intercollegiate Guidelines Network (SIGN). Guideline No. 123 http://www.sign.ac.uk/guidelines/fulltext/123/index.html
Literature
- Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet 2010 Sep 25;376(9746):1094-108. [PubMed]
- Aletaha D, Neogi T, Silman AJ et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62(9):2569-81. [PubMed]
Primary/Secondary Keywords